Pharmacological Preconditioning Using Intraportal Infusion of L-Arginine Protects Against Hepatic Ischemia Reperfusion Injury

Journal of Surgical Research

Volumn 155, Issue 2, 2009, Pages 244-253

  Giovanardi, Rafael Omar ^a,b   Rhoden, Ernani Luis ^a   Cerski, Carlos Thadeu ^a   Salvador, Miriam ^b   Kalil, Antonio Nocchi ^c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSITY OF CAXIAS DO SUL   (Brazil)

^c UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

apoptosis; ischemia reperfusion; L arginine; liver injury; nitric oxide

Indexed keywords

ALANINE AMINOTRANSFERASE; ARGININE; ASPARTATE AMINOTRANSFERASE; CASPASE 3; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE FLOW; CELL INFILTRATION; CELL STRUCTURE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CELL; LIVER FUNCTION; LIVER ISCHEMIA; LIVER SINUSOID; MITOCHONDRION; NEUTROPHIL; NONHUMAN; PRESERVATION; PRIORITY JOURNAL; SINUS CONGESTION;

ALANINE TRANSAMINASE; ANIMALS; ARGININE; ASPARTATE AMINOTRANSFERASES; CASPASE 3; DISEASE MODELS, ANIMAL; FEMALE; INFUSIONS, INTRAVENOUS; ISCHEMIC PRECONDITIONING; LIVER; MITOCHONDRIA, LIVER; NITRIC OXIDE; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SWINE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 67650941644     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.07.002     Document Type: Article

References (52)

1. Koti R.S., Seifalian A.M., and Davidson B.R. Protection of the liver by ischemic preconditioning: A review of mechanisms and clinical applications. Dig Surg 20 (2003) 383
2. Koti R.S., Tsui J., Lobos E., et al. Nitric oxide synthase distribution and expression with ischemic preconditioning of the rat liver. FASEB 19 (2005) 1155
3. Rudiger H.A., Graf R., and Clavien P.A. Liver ischemia: Apoptosis as a central mechanism of injury. J Invest Surg 16 (2003) 149
4. Peralta C., Rull R., Rimola A., et al. Endogenous nitric oxide and exogenous nitric oxide supplementation in hepatic ischemia-reperfusion injury in the rat. Transplantation 71 (2001) 529
5. Shah V., and Kamath P.S. Nitric oxide in liver transplantation: Pathobiology and clinical implications. Liver Transpl 9 (2003) 1
6. Yagnik G.P., Takahashi Y., Tsoulfas G., et al. Blockade of the L-arginine/NO synthase pathway worsens hepatic apoptosis and liver transplant preservation injury. Hepatology 36 (2002) 573
7. Pryor W.A., and Squadrito G.L. The chemistry of peroxynitrite: A product from the reaction of nitric oxide with superoxide. Am J Physiol 268 (1995) L699
8. Kim J.S., Ohshima S., Pediaditakis P., et al. Nitric oxide protects rat hepatocytes against reperfusion injury mediated by the mitochondrial permeability transition. Hepatology 39 (2004) 1533
9. Kim Y.M., Kim T.H., Chung H.T., et al. Nitric oxide prevents tumor necrosis factor α-induced rat hepatocyte apoptosis by the interruption of mitochondrial apoptotic signaling through S-nitrosylation of caspase-8. Hepatology 32 (2000) 770
10. Torok N.J., Higuchi H., Bronk S., et al. Nitric oxide inhibits apoptosis downstream of cytochrome c release by nitrosylating caspase 9. Cancer Res 62 (2002) 1648
11. Mannick J.B., Hausladen A., Liu L., et al. Fas-induced caspase denitrosylation. Science 284 (1999) 651
12. Ohmori H., Dhar D.K., Nakashima Y., et al. Beneficial effects of FK409, a novel nitric oxide donor, on reperfusion injury of rat liver. Transplantation 66 (1998) 579
13. Cottart C.H., Do L., Blanc M.C., et al. Hepatoprotective effect of endogenous nitric oxide during ischemia-reperfusion in the rat. Hepatology 29 (1999) 809
14. Geller D.A., Chia S.H., Takahashi Y., et al. Protective role of the L-arginine-nitric oxide synthase pathway on preservation injury after rat liver transplantation. JPEN J Parenter Enteral Nutr 25 (2001) 142
15. Koeppel T.A., Thies J.C., Schemmer P., et al. Inhibition of nitric oxide synthesis in ischemia/reperfusion of the rat liver is followed by impairment of hepatic microvascular blood flow. J Hepatol 27 (1997) 163
16. Kobayashi H., Nonami T., Kurokawa T., et al. Role of endogenous nitric oxide in ischemia-reperfusion injury in rat liver. J Surg Res 59 (1995) 772
17. Shiraishi M., Hiroyasu S., Nagahama M., et al. Role of exogenous L-arginine in hepatic ischemia-reperfusion injury. J Surg Res 69 (1997) 429
18. Ferraresso M., Burra P., Cadrobbi R., et al. Protective effect of L-arginine on liver ischemia-reperfusion injury. Transplant Proc 29 (1997) 393
19. Calabrese F., Valente M., Pettenazzo E., et al. The protective effects of L-arginine after liver ischemia/reperfusion injury in a pig model. J Pathol 183 (1997) 477
20. Squadrito G., and Pryor W.A. Oxidative chemistry of nitric oxide: The roles of superoxide, peroxynitrite, and carbon dioxide. Free Radic Biol Med 25 (1998) 392
21. Billiar T.R. The delicate balance of nitric oxide and superoxide in liver pathology. Gastroenterology 108 (1995) 603
22. Beckman J.S., and Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. Am J Physiol 271 (1996) C1424
23. Meguro M., Katsuramaki T., Nagayama M., et al. A novel inhibitor of inducible nitric oxide synthase (ONO-1714) prevents critical warm ischemia-reperfusion injury in the pig liver. Transplantation 73 (2002) 1439
24. Menezes J., Hierholzer C., Watkins S.C., et al. A novel nitric oxide scavenger decreases liver injury and improves survival after hemorrhagic shock. Am J Physiol 277 (1999) G144
25. Wang Y., Mathews W.R., Guido D.M., et al. Inhibition of nitric oxide synthesis aggravates reperfusion injury after hepatic ischemia and endotoxemia. Shock 4 (1995) 282
26. Liu P., Yin K., Nagele R., et al. Inhibition of nitric oxide synthase attenuates peroxynitrite generation, but augments neutrophil accumulation in hepatic ischemia-reperfusion in rats. J Pharmacol Exp Ther 284 (1998) 1139-1146
27. Wills E.D. Mechanisms of lipid peroxide formation in animal tissues. Biochem J 99 (1966) 667
28. Reynolds E.S. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol 17 (1963) 208
29. Altman D.G. Statistics in medical journals: Developments in the 1980s. Stat Med 10 (1991) 1897
30. Spiegel H.U., and Bahde R. Experimental models of temporary normothermic liver ischemia. J Invest Surg 19 (2006) 113
31. Selzner M., Rudiger H.A., Sindram D., et al. Mechanisms of ischemic injury are different in the steatotic and normal rat liver. Hepatology 32 (2000) 1280
32. Casillas-Ramirez A., Mosbah I.B., Ramalho F., et al. Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation. Life Sci 79 (2006) 1881
33. Lanteri R., Acquaviva R., Di Giacomo C., et al. Heme oxygenase 1 expression in postischemic reperfusion liver damage: Effect of L-arginine. Microsurgery 26 (2006) 25
34. Shimamura T., Zhu Y., Zhang S., et al. Protective role of nitric oxide in ischemia and reperfusion injury of the liver. J Am Coll Surg 188 (1999) 43
35. Burra P., Chirizzi L., Cardin R., et al. Warm hepatic ischemia in pigs: Effects of L-arginine and oligotide treatment. J Invest Surg 14 (2001) 303
36. van Wagensveld B.A., van Gulik T.M., Gelderblom H., et al. Prolonged continuous or intermittent vascular inflow occlusion during hemihepatectomy in pigs. Ann Surg 229 (1999) 376
37. Bowers B.A., Branum G.D., Rotolo F.S., et al. Bile flow-an index of ischemic injury. J Surg Res 42 (1987) 565
38. Szijarto A., Hahn O., Lotz G., et al. Effect of ischemic preconditioning on rat liver microcirculation monitored with laser Doppler flowmetry. J Surg Res 131 (2006) 150
39. Nieuwenhuijs V.B., de Bruijn M.T., Schiesser M., et al. Ischemic preconditioning and intermittent ischemia preserve bile flow in a rat model of ischemia/reperfusion injury. Dig Dis Sci (2007) 1159
40. Jaeschke H. Role of reactive oxygen species in hepatic ischemia-reperfusion injury and preconditioning. J Invest Surg 16 (2003) 127
41. Jaeschke H. Reactive oxygen and mechanisms of inflammatory liver injury. Gastroenterol Hepatol 15 (2000) 718
42. Murphy H.S., Warner R.L., Bakopoulos N., et al. Endothelial cell determinants of susceptibility to neutrophil-mediated killing. Shock 12 (1999) 111
43. Helling T.S., Edwards C.A., Helling Jr. T.S., et al. Hepatic apoptotic activity following transient normothermic inflow occlusion and reperfusion in the swine model. J Surg Res 86 (1999) 70
44. Kimura H., Katsuramaki T., Isobe M., et al. Role of inducible nitric oxide synthase in pig liver transplantation. J Surg Res 111 (2003) 28
45. Schulz R., Walz M.K., Behrends M., et al. Minimal protection of the liver by ischemic preconditioning in pigs. Am J Physiol Heart Circ Physiol 280 (2001) H198
46. Murphy A. Potential mechanisms of mitochondrial cytochrome c release furing apoptosis. Drug Dev Res 46 (1999) 18
47. Lemasters J.J.V. Necrapoptosis and the mitochondrial permeability transition: Shared pathways to necrosis and apoptosis Am J. Physiol 276 (1999) G1
48. Kluck R.M., Bossy-Wetzel E., Green D.R., et al. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 275 (1997) 1132
49. Zamzami N., Susin S.A., Marchetti P., et al. Mitochondrial control of nuclear apoptosis. J Exp Med 183 (1996) 1533
50. Mancini M., Nicholson D.W., Roy S., et al. The caspase-3 precursor has a cytosolic and mitochondrial distribution: Implications for apoptotic signaling. J Cell Biol 140 (1998) 1485
51. Miller D.K. The role of the Caspase family of cysteine proteases in apoptosis. Semin Immunol 9 (1997) 35
52. Higa T., Shiraishi M., Mamadi T., et al. Limitations of exogenous L-arginine in exerting a cytoprotective effect on hepatic ischemia/reperfusion injury. Surg Today 30 (2000) 352